Health Technology Assessment (Nov 2006)
The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation
Abstract
No abstracts available.
Health Technology Assessment (Nov 2006)